These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 1029185)

  • 1. [The significance of age for morphological and biochemical changes in galactosamine hepatitis].
    Platt D
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 1():249-51. PubMed ID: 1029185
    [No Abstract]   [Full Text] [Related]  

  • 2. Galactosamine- "hepatitis" in rats with different phagocytic activity of liver RES.
    Rasenack U; Grün M; Liehr H
    Acta Hepatogastroenterol (Stuttg); 1975 Feb; 22(1):29-35. PubMed ID: 1119301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Biochemical and morphological studies of galactosamine-hepatitis in the rat].
    Meyer-Burg J; Grohme S; Bungert HJ; Körtge P
    Klin Wochenschr; 1971 May; 49(9):562-3. PubMed ID: 5581600
    [No Abstract]   [Full Text] [Related]  

  • 4. Significance of endotoxaemia in experimental "galactosamine-hepatitis" in the rat.
    Grün M; Liehr H; Rasenack U
    Acta Hepatogastroenterol (Stuttg); 1977 Apr; 24(2):64-81. PubMed ID: 857560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The importance of intestinal endotoxins for the rise of toxic liver lesions from galactosamine].
    Grün M; Liehr H; Rasenack U
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 1():251-60. PubMed ID: 800910
    [No Abstract]   [Full Text] [Related]  

  • 6. A comparison between the morphologic changes in the livers of hamsters and rats after galactosamine treatment and their correlation with altered serum transaminase levels.
    Pickering RW
    Arzneimittelforschung; 1977; 27(9):1684-7. PubMed ID: 579138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Influence of bilateral adrenalectomy on acute galactosamine lesions in the rat].
    Lesch R; Deus B; Reutter W
    Verh Dtsch Ges Inn Med; 1972; 78():1380-3. PubMed ID: 4665552
    [No Abstract]   [Full Text] [Related]  

  • 8. Influence of liver-RES on toxic liver damage due to galactosamine.
    Grün M; Liehr H; Grün W; Rasenack U; Brunswig D
    Acta Hepatogastroenterol (Stuttg); 1974 Feb; 21(1):5-15. PubMed ID: 4450963
    [No Abstract]   [Full Text] [Related]  

  • 9. [Aggravation of acute galactosamine hepatitis by a sodic bicarbonated water in rats (author's transl)].
    de La Tour J; Souchard M; Chariot J; Rozé C; Potet F; Vaille C
    J Pharmacol; 1981; 12(1):37-50. PubMed ID: 6261045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of prednisolone on the development of the galactosamine hepatitis of young and old rats (author's transl)].
    Platt D; Leinweber B; Förster L; Förster K
    Aktuelle Gerontol; 1976 Jun; 6(6):267-78. PubMed ID: 14531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lipid metabolism and liver function in D-galactosamine poisoning in rats].
    Vengerovskiĭ AI; Saratikov AS
    Patol Fiziol Eksp Ter; 1988; (3):52-5. PubMed ID: 3174253
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of the liver protecting compound ES 914 on D-galactosamine induced experimental hepatitis in the rat].
    Wegmann A; Chariatte N; Renker H; Dittrich A
    Arzneimittelforschung; 1979; 29(1):68-70. PubMed ID: 582121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevention of galactosamine hepatitis using administration of D-galactose: significance of temporally limited UDP-galactose deficit for the induction of galactosamine hepatitis].
    Bauer C; Reutter W; Bachmann W; Lesch R
    Hoppe Seylers Z Physiol Chem; 1972 Oct; 353(10):1502. PubMed ID: 4649767
    [No Abstract]   [Full Text] [Related]  

  • 14. The protective effect of a novel compound RU 18492, on galactosamine-induced hepatotoxicity in the rat.
    James GW; Pickering RW
    Arzneimittelforschung; 1976; 26(12):2197-9. PubMed ID: 1037274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Protective and curative effects of diethyldithiocarbamate on galactosamine hepatitis in the rat (author's transl)].
    Homann J; Gerhardt H; Hopf F
    Arzneimittelforschung; 1980; 30(4):645-7. PubMed ID: 6249330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ["Galactosamine refractory" regenerating liver--a model for studies on the etiology mechanism of galactosamine hepatitis].
    Reutter W; Bauer C; Bachmann W; Lesch R
    Hoppe Seylers Z Physiol Chem; 1972 May; 353(5):747. PubMed ID: 5069316
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of fasting on galactosamine induced hepatitis in experimental animals.
    Pickering RW
    Arzneimittelforschung; 1977; 27(10):1992-6. PubMed ID: 579109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of tyrosine aminotransferase in galactosamine hepatitis.
    Pugge HR; Torrecilla A; Pellanda RJ
    Acta Gastroenterol Latinoam; 1979; 9(3):159-63. PubMed ID: 43646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective role of prednisolone upon galactosamine-induced hepatitis in rats.
    Grases PJ; Reutter W; Lesch R
    G E N; 1972; 27(2):197-204. PubMed ID: 4201408
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of essential phospholipids on the galactosamine hepatitis in rats].
    Petzold H; Titlbach O
    Cesk Gastroenterol Vyz; 1974 Apr; 28(3):178-80. PubMed ID: 4447983
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.